Dabigatran etexilate – a novel, reversible, oral direct thrombin inhibitor: Interpretation of coagulation assays and reversal of anticoagulant activity
Year: 2010
Type: article
Source: Thrombosis and Haemostasis
DOI: 10.1160/th09-11-0758
Institution: Boehringer Ingelheim (Germany)
Language: English
Subfield: Internal Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2113446992
